scholarly article | Q13442814 |
P356 | DOI | 10.1038/S41380-020-00912-2 |
P698 | PubMed publication ID | 33077856 |
P50 | author | Michael Owen | Q17198421 |
George Kirov | Q30004103 | ||
Michael C O'Donovan | Q30410265 | ||
Nicholas E Clifton | Q47162727 | ||
Antonio F Pardiñas | Q47232297 | ||
Andrew Pocklington | Q60666480 | ||
Jeremy Hall | Q61800399 | ||
P2093 | author name string | Peter A Holmans | |
James T R Walters | |||
Arianna Di Florio | |||
Elliott Rees | |||
Janet C Harwood | |||
P2860 | cites work | The Kraepelinian dichotomy - going, going... but still not gone | Q22241683 |
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease | Q22251067 | ||
Rare chromosomal deletions and duplications increase risk of schizophrenia | Q22337245 | ||
The fragile X syndrome protein represses activity-dependent translation through CYFIP1, a new 4E-BP | Q24314573 | ||
Altered synaptic plasticity in a mouse model of fragile X mental retardation | Q24530695 | ||
Biological insights from 108 schizophrenia-associated genetic loci | Q24561833 | ||
CNV analysis in a large schizophrenia sample implicates deletions at 16p12.1 and SLC1A1 and duplications at 1p36.33 and CGNL1 | Q24603800 | ||
FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism | Q24631425 | ||
A global reference for human genetic variation | Q25909434 | ||
Analysis of protein-coding genetic variation in 60,706 humans | Q26831376 | ||
Learning and behavioral deficits associated with the absence of the fragile X mental retardation protein: what a fly and mouse model can teach us. | Q26866506 | ||
Evidence that fragile X mental retardation protein is a negative regulator of translation | Q28117211 | ||
FMRP targets distinct mRNA sequence elements to regulate protein expression | Q28117931 | ||
Synaptic, transcriptional and chromatin genes disrupted in autism | Q28250800 | ||
The contribution of de novo coding mutations to autism spectrum disorder | Q28250812 | ||
Novel Findings from CNVs Implicate Inhibitory and Excitatory Signaling Complexes in Schizophrenia | Q28262977 | ||
Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome | Q28273791 | ||
Copy number variants in schizophrenia: confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications | Q28304430 | ||
Metabotropic glutamate receptor activation regulates fragile x mental retardation protein and FMR1 mRNA localization differentially in dendrites and at synapses | Q28576233 | ||
Beyond the looking glass: recent advances in understanding the impact of environmental exposures on neuropsychiatric disease | Q89938769 | ||
Widespread RNA editing dysregulation in brains from autistic individuals | Q90597084 | ||
De novo mutations identified by exome sequencing implicate rare missense variants in SLC6A1 in schizophrenia | Q92611022 | ||
The FXG: a presynaptic fragile X granule expressed in a subset of developing brain circuits | Q28588310 | ||
The fragile X mental retardation protein inhibits translation via interacting with mRNA | Q28588486 | ||
Fragile X mental retardation protein deficiency leads to excessive mGluR5-dependent internalization of AMPA receptors | Q28771397 | ||
CYFIP1 coordinates mRNA translation and cytoskeleton remodeling to ensure proper dendritic spine formation | Q28910185 | ||
A framework for the interpretation of de novo mutation in human disease | Q29031873 | ||
De Novo Gene Disruptions in Children on the Autistic Spectrum | Q29394534 | ||
Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome | Q29616495 | ||
De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia. | Q30454132 | ||
MAGMA: generalized gene-set analysis of GWAS data | Q30935493 | ||
De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. | Q33398247 | ||
Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants | Q33604879 | ||
De novo mutations in schizophrenia implicate chromatin remodeling and support a genetic overlap with autism and intellectual disability | Q33650848 | ||
Genomic insights into the overlap between psychiatric disorders: implications for research and clinical practice. | Q33772616 | ||
A polygenic burden of rare disruptive mutations in schizophrenia | Q34060200 | ||
Analysis of FMRP mRNA target datasets reveals highly associated mRNAs mediated by G-quadruplex structures formed via clustered WGGA sequences | Q34211875 | ||
De novo mutations in schizophrenia implicate synaptic networks | Q34540372 | ||
Exome sequencing in 53 sporadic cases of schizophrenia identifies 18 putative candidate genes | Q34566077 | ||
Copy number variation in schizophrenia in Sweden | Q34742638 | ||
Activity-dependent FMRP requirements in development of the neural circuitry of learning and memory | Q35228888 | ||
Loss-of-function variants in schizophrenia risk and SETD1A as a candidate susceptibility gene | Q35296003 | ||
Increased co-expression of genes harboring the damaging de novo mutations in Chinese schizophrenic patients during prenatal development | Q36371011 | ||
Fragile X syndrome: causes, diagnosis, mechanisms, and therapeutics. | Q36498006 | ||
Exome arrays capture polygenic rare variant contributions to schizophrenia. | Q36581392 | ||
Psychiatric classifications: validity and utility | Q36657877 | ||
Psychiatric gene discoveries shape evidence on ADHD's biology | Q36763139 | ||
De novo variants in sporadic cases of childhood onset schizophrenia | Q36902721 | ||
Support for the involvement of large copy number variants in the pathogenesis of schizophrenia | Q37147142 | ||
Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia | Q37407215 | ||
Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network | Q37487752 | ||
Analysis of copy number variations at 15 schizophrenia-associated loci. | Q37541157 | ||
Expansion of the Gene Ontology knowledgebase and resources | Q37556864 | ||
Fragile X mental retardation protein control of neuronal mRNA metabolism: Insights into mRNA stability | Q37616726 | ||
Genetic relationships between schizophrenia, bipolar disorder, and schizoaffective disorder | Q37699386 | ||
Genetic risk for schizophrenia: convergence on synaptic pathways involved in plasticity | Q38242794 | ||
New approaches to psychiatric diagnostic classification | Q38274354 | ||
Multifarious Functions of the Fragile X Mental Retardation Protein | Q38639448 | ||
Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects | Q39217627 | ||
Analysis of Intellectual Disability Copy Number Variants for Association With Schizophrenia | Q39414858 | ||
Mutation intolerant genes and targets of FMRP are enriched for nonsynonymous alleles in schizophrenia | Q40118681 | ||
The contribution of rare variants to risk of schizophrenia in individuals with and without intellectual disability. | Q40145512 | ||
Fragile X mental retardation protein is associated with translating polyribosomes in neuronal cells. | Q40524276 | ||
Exome Sequencing of Familial Bipolar Disorder | Q40779420 | ||
Fmrp targets or not: long, highly brain-expressed genes tend to be implicated in autism and brain disorders | Q41194358 | ||
Schizophrenia and the neurodevelopmental continuum:evidence from genomics | Q41658777 | ||
Roles of CREB in the regulation of FMRP by group I metabotropic glutamate receptors in cingulate cortex. | Q42057289 | ||
Schizophrenia copy number variants and associative learning | Q42325307 | ||
Fragile X mental retardation protein is required for chemically-induced long-term potentiation of the hippocampus in adult mice. | Q43297720 | ||
NMDA receptor hypofunction in the dentate gyrus and impaired context discrimination in adult Fmr1 knockout mice | Q45349101 | ||
FMRP acts as a key messenger for dopamine modulation in the forebrain | Q46400113 | ||
Mouse Genome Database (MGD)-2018: knowledgebase for the laboratory mouse | Q47202657 | ||
Gene-set analysis shows association between FMRP targets and autism spectrum disorder | Q47745129 | ||
The implications of the shared genetics of psychiatric disorders | Q47895165 | ||
RNA cargoes associating with FMRP reveal deficits in cellular functioning in Fmr1 null mice. | Q48392342 | ||
Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice. | Q48569575 | ||
Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection. | Q50301210 | ||
A phenotypic and molecular characterization of the fmr1-tm1Cgr fragile X mouse. | Q50307286 | ||
Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. | Q52560096 | ||
Genome-wide association study of depression phenotypes in UK Biobank identifies variants in excitatory synaptic pathways. | Q52584632 | ||
Linking the SWI/SNF complex to prostate cancer. | Q52644728 | ||
Genetic and maternal predictors of cognitive and behavioral trajectories in females with fragile X syndrome. | Q55287271 | ||
Increased exonic de novo mutation rate in individuals with schizophrenia | Q59667688 | ||
Genome-wide association study identifies 30 loci associated with bipolar disorder. | Q63433064 | ||
Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions | Q63433067 | ||
Targeted Sequencing of 10,198 Samples Confirms Abnormalities in Neuronal Activity and Implicates Voltage-Gated Sodium Channels in Schizophrenia Pathogenesis | Q64088951 | ||
Genetic and environmental influences on the cognitive outcomes of children with fragile X syndrome | Q77747383 | ||
FMRP has a cell-type-specific role in CA1 pyramidal neurons to regulate autism-related transcripts and circadian memory | Q83225464 | ||
HITS-CLIP in various brain areas reveals new targets and new modalities of RNA binding by fragile X mental retardation protein | Q88398634 | ||
Postsynaptic FMRP Regulates Synaptogenesis In Vivo in the Developing Cochlear Nucleus | Q89295073 | ||
P577 | publication date | 2020-10-19 | |
P1433 | published in | Molecular Psychiatry | Q6895973 |
P1476 | title | Genetic association of FMRP targets with psychiatric disorders |
Search more.